HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 85-96 of 1,979
Other study type icon
UnknownNCT06497868

Self-compassion and Bipolarity

Official study title

Self-compassion and Bipolar Disorder: Evaluation of the Feasibility and Preliminary Effectiveness of Two Psychological Therapies Targeting Self-compassion

Current recruitment status is unconfirmed.

In Strasbourg
BipolarityObservational studyAges 18+
Countries
France
Sponsor
University Hospital, Strasbourg, France
Drug study icon
CompletedNCT00107939

Licarbazepine in the Treatment of manic episodes of Bipolarity

What is this study about?

This study evaluated the safety and effectiveness of Licarbazepine for people with bipolarity.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–70
Countries
United States
Sponsor
Novartis Pharmaceuticals
Drug study icon
CompletedNCT03287869

Brexpiprazole for Bipolarity

What is this study about?

Researchers studied Brexpiprazole, tracking side effects to assess safety and tolerability in people with bipolarity type I.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
BipolarityMedication studyAges 18–65
Countries
United States, Bulgaria, Croatia, + 3 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00181779

Aripiprazole for Mania in Children and Adolescents With Bipolarity

Official study title

Open-Label Pilot Study of Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder

This study has finished and is no longer accepting participants.

In Cambridge
BipolarityMedication studyAges 6–17
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00181870

Equetro for Mania in Children Ages 6-12 With Bipolarity

Official study title

Open-Label Study of Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder

This study has finished and is no longer accepting participants.

In Cambridge
BipolarityMedication studyAges 6–12
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00181844

Lamotrigine for Mania in Youth Ages 6-17 With Bipolarity

What is this study about?

Researchers studied lamotrigine to find out how it affected manic symptoms in young people with bipolarity type II during a manic episode.

This study has finished and is no longer accepting participants.

In Cambridge
BipolarityMedication studyAges 6–17
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00280566

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolarity type I (Manic or Mixed)

Official study title

A Phase 3, Randomized, 6-Month, Double-Blind Trial in Subjects With Bipolar I Disorder to Evaluate the Continued Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer (vs Placebo Plus a Mood Stabilizer) Following a Minimum of 2 Months of Response to Open-Label Treatment With Both Agents

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
BipolarityMedication studyAges 18+
Countries
United States, France, Chile, + 10 others
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Drug study icon
CompletedNCT00181727

Depakote ER for Mania in Children Ages 6-12 With Bipolarity

Official study title

Open-Label Study of Divalproex Sodium Extended Release for the Treatment of Mania in Children Ages 6-12 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder

This study has finished and is no longer accepting participants.

In Cambridge
BipolarityMedication studyAges 6–12
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Device study icon
Active Not RecruitingNCT06482762

Low-Intensity Focused Ultrasound of the Amygdala for Bipolarity

Official study title

Low-Intensity Focused Ultrasound of the Amygdala for Bipolar Disorder

This study is no longer accepting new participants.

In Boston
BipolarityDevice studyAges 18–64
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Other study type icon
CompletedACTRN12606000440527

Omega-3 fatty acids in the treatment of children and adolescents with Bipolarity

Official study title

An open-label study to evaluate the effects of omega-3 polyunsaturated fatty acids delivered in tuna oil in the treatment of children and adolescents with bipolar disorder to improve symptoms of mania and depression

This study has finished and is no longer accepting participants.

Location not clearly listed
BipolarityInterventional studyAges 8–18
Countries
Sponsor
Professor Philip Hazell

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.